Ensysce Biosciences Stock Price on December 2, 2024
ENSC Stock | USD 0.55 0.04 6.78% |
Below is the normalized historical share price chart for Ensysce Biosciences extending back to February 26, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ensysce Biosciences stands at 0.55, as last reported on the 3rd of December, with the highest price reaching 0.59 and the lowest price hitting 0.53 during the day.
If you're considering investing in Ensysce Stock, it is important to understand the factors that can impact its price. Ensysce Biosciences is abnormally volatile given 3 months investment horizon. Ensysce Biosciences secures Sharpe Ratio (or Efficiency) of 0.0987, which denotes the company had a 0.0987% return per unit of risk over the last 3 months. We are able to interpolate and collect twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.28% are justified by taking the suggested risk. Use Ensysce Biosciences Mean Deviation of 10.86, coefficient of variation of 1052.09, and Downside Deviation of 10.76 to evaluate company specific risk that cannot be diversified away.
At present, Ensysce Biosciences' Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 127.3 M, whereas Total Stockholder Equity is projected to grow to (306.7 K). . As of December 3, 2024, Price To Sales Ratio is expected to decline to 1.02. In addition to that, Price Earnings Ratio is expected to decline to -0.24. Ensysce Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of February 2018 | 200 Day MA 0.539 | 50 Day MA 0.4139 | Beta 0.639 |
Ensysce |
Sharpe Ratio = 0.0987
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ENSC | |||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
23.1 actual daily | 96 96% of assets are less volatile |
Expected Return
2.28 actual daily | 45 55% of assets have higher returns |
Risk-Adjusted Return
0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Ensysce Biosciences is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ensysce Biosciences by adding it to a well-diversified portfolio.
Price Book 1.6717 | Enterprise Value Ebitda (0.50) | Price Sales 8.0314 | Shares Float 6.7 M | Wall Street Target Price 6.8 |
Related Headline
Revelation Biosciences Headline on 2nd of December 2024
REVB Gets FDA Go Ahead by finance.yahoo.com
By Brad Sorensen, CFA NASDAQREVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences announced that the FDA has accepted the companys IND application for Gemini. This announcement allows the Company to initiate its US based Phase 1b clinical study to evaluate the potential of Gemini as a preconditioning treatment in patients with chronic kidney disease . This is
Ensysce Biosciences Valuation on December 2, 2024
It is possible to determine the worth of Ensysce Biosciences on a given historical date. On December 2, 2024 Ensysce was worth 0.51 at the beginning of the trading date compared to the closed value of 0.59. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ensysce Biosciences stock. Still, in general, we apply an absolute valuation method to find Ensysce Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ensysce Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ensysce Biosciences' related companies.
Open | High | Low | Close | Volume | |
0.49 | 0.53 | 0.48 | 0.49 | 551,600 | |
12/02/2024 | 0.51 | 0.62 | 0.48 | 0.59 | 2,261,304 |
0.59 | 0.59 | 0.53 | 0.55 | 1,062,291 |
Backtest Ensysce Biosciences | | | Ensysce Biosciences History | | | Ensysce Biosciences Valuation | Previous | Next |
Ensysce Biosciences Trading Date Momentum on December 2, 2024
On December 03 2024 Ensysce Biosciences was traded for 0.55 at the closing time. The top price for the day was 0.59 and the lowest listed price was 0.53 . The trading volume for the day was 1.1 M. The trading history from December 3, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 6.78% . The overall trading delta against the current closing price is 0.00% . |
Ensysce Biosciences Fundamentals Correlations and Trends
By evaluating Ensysce Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ensysce Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ensysce financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ensysce Biosciences Stock history
Ensysce Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ensysce is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ensysce Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ensysce Biosciences stock prices may prove useful in developing a viable investing in Ensysce Biosciences
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 2.3 M | 3.9 M | |
Net Loss | -22.6 M | -21.4 M |
Ensysce Biosciences Stock Technical Analysis
Ensysce Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Ensysce Biosciences Period Price Range
Low | December 3, 2024
| High |
0.00 | 0.00 |
Ensysce Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ensysce Biosciences December 3, 2024 Market Strength
Market strength indicators help investors to evaluate how Ensysce Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ensysce Biosciences shares will generate the highest return on investment. By undertsting and applying Ensysce Biosciences stock market strength indicators, traders can identify Ensysce Biosciences entry and exit signals to maximize returns
Ensysce Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ensysce Biosciences' price direction in advance. Along with the technical and fundamental analysis of Ensysce Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ensysce to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0823 | |||
Jensen Alpha | 2.25 | |||
Total Risk Alpha | (1.25) | |||
Sortino Ratio | 0.1895 | |||
Treynor Ratio | (2.44) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Ensysce Stock analysis
When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |